Cancer News Genetics May Predict Bladder Cancer Immunotherapy Response Science Daily

Scientists Identify ALYREF Biomarker That Could Transform Bladder Cancer Treatment

Discover how the ALYREF biomarker predicts bladder cancer aggressiveness and boosts immunotherapy response. Find out more about its potential. Read More

Missing cancer gene may boost response to immunotherapy

A recently approved group of drugs - immune checkpoint inhibitors - can boost the body's ability to eliminate a tumor and even keep the cancer from coming back. However, while the medications work ... Read More

Scientists just cracked the mystery of why cancer immunotherapy fails

Ohio State researchers have discovered that exhausted T cells collapse under the weight of misfolded proteins, activating a destructive stress response called TexPSR. Unlike normal stress systems, ... Read More

Can AI predict cancer? New model uses genomics to simulate tumors

A team of scientists has developed a remarkable new approach to modeling how cells behave over time—using a digital "forecast" much like predicting the weather. By combining patient genomics with a ... Read More

A hormone that silences the immune system may unlock new cancer treatments

Scientists have discovered that cancer uses a hidden hormone to switch off the body’s natural defenses, allowing tumors to grow unchecked. By uncovering this secret signal, they found a way to block ... Read More

Rare mutation may predict strong immunotherapy response in colorectal cancer

A new study led by researchers at The University of Texas MD Anderson Cancer Center shows that a specific subset of mutations in the POLE gene is strongly associated with durable responses to ... Read More

Tiny implant wipes out bladder cancer in 82% of patients

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ... Read More

What to know about Anktiva, the cancer drug that doesn’t use chemotherapy

Anktiva is combined with BCG, or Bacillus Calmette-Guérin, an immunotherapy drug delivered to the bladder through a catheter. It’s intended for people who have non-muscle invasive bladder cancer, or ... Read More

A common supplement could reverse the hidden harm of sucralose

Sucralose, the sugar substitute in many diet products, may weaken cancer immunotherapy by altering gut bacteria and reducing arginine levels needed for immune cells. But supplementation with arginine ... Read More